Stock(AMB) – Quarterly Progress Report (Non-Cumulative)
Quarterly Progress Report (QPR) on age-group wise service deliveries and information on distribution of Iron and Folic Acid (IFA) syrup and tablets- Pink, Blue & Red, Albendazole tablets among the 6 focused age groups. The information is derived on the basis of data updates available from HMIS indicators (Numerator) calculated using the eligible age specific respective denominators for each age group. *The GOI quarter reporting year starts from April and ends in March of the subsequent year (Q1-April to June, Q2-July to September, Q3- October to December and Q4 January to March (of subsequent year)).
Maternal Nutrition in Percentage
INDIA
Maternal Calcium
| Year | Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|---|
| HMIS 19.16: Number of Stocks Received for Calcium Tablets | 2020-21 | 6.3 | 5.1 | 3.1 | 3.4 |
| HMIS 19.16: Number of Stocks Received for Calcium Tablets | 2019-20 | 4.7 | 5.2 | 5.4 | 7.1 |
| HMIS 19.16: Number of Stocks Received for Calcium Tablets | 2018-19 | 5.0 | 2.5 | 2.0 | 6.9 |
| HMIS 19.16: Number of Stocks Received for Calcium Tablets | 2017-18 | 1.5 | 1.7 | 1.8 | 1.9 |
| HMIS 19.16: Number of Stocks Distributed for Calcium Tablets | 2020-21 | 8.2 | 5.3 | 4.6 | 3.8 |
| HMIS 19.16: Number of Stocks Distributed for Calcium Tablets | 2019-20 | 3.8 | 4.0 | 5.7 | 6.6 |
| HMIS 19.16: Number of Stocks Distributed for Calcium Tablets | 2018-19 | 2.6 | 2.5 | 2.7 | 2.3 |
| HMIS 19.16: Number of Stocks Distributed for Calcium Tablets | 2017-18 | 1.8 | 2.1 | 1.9 | 1.9 |
| HMIS 19.16: Number of Stocks available for Iron Calcium Tablets | 2020-21 | 27.1 | 27.2 | 17.0 | 16.7 |
| HMIS 19.16: Number of Stocks available for Iron Calcium Tablets | 2019-20 | 11.7 | 18.9 | 15.3 | 15.3 |
| HMIS 19.16: Number of Stocks available for Iron Calcium Tablets | 2018-19 | 9.3 | 9.8 | 10.9 | 9.0 |
| HMIS 19.16: Number of Stocks available for Iron Calcium Tablets | 2017-18 | 3.8 | 3.9 | 3.2 | 3.7 |
Stock KPI (AMB)
IFA Red Adult| Year | Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|---|
| 2021-22 | 34.8 | 18.8 | 0.2 | 29.8 | |
| 2021-22 | 34.8 | 18.8 | 0.2 | 29.8 | |
| HMIS 19.6: Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult) | 2020-21 | 23.3 | 31.0 | 30.6 | 30.2 |
| 2020-21 | 23.3 | 31.0 | 30.6 | 30.2 | |
| HMIS 19.6: Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult) | 2019-20 | 34.3 | 31.5 | 29.9 | 19.6 |
| 2019-20 | 34.3 | 31.5 | 29.9 | 19.6 | |
| HMIS 19.6: Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult) | 2018-19 | 23.7 | 28.2 | 31.1 | 24.5 |
| 2018-19 | 23.7 | 28.2 | 31.1 | 24.5 | |
| HMIS 19.6: Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult) | 2017-18 | 14.1 | 35.6 | 26.2 | 23.8 |
| 2017-18 | 14.1 | 35.6 | 26.2 | 23.8 | |
| HMIS 19.6: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Red(Adult) | 2020-21 | 9.0 | 20.2 | 9.9 | 13.6 |
| HMIS 19.6: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Red(Adult) | 2019-20 | 12.0 | 8.1 | 8.6 | 2.9 |
| HMIS 19.6: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Red(Adult) | 2018-19 | 7.5 | 10.4 | 13.4 | 6.0 |
| HMIS 19.6: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Red(Adult) | 2017-18 | 5.3 | 16.6 | 11.7 | 5.3 |
| HMIS 19.6: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Red(Adult) | 2020-21 | 8.0 | 11.9 | 7.1 | 11.5 |
| HMIS 19.6: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Red(Adult) | 2019-20 | 7.4 | 9.9 | 11.4 | 5.2 |
| HMIS 19.6: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Red(Adult) | 2018-19 | 9.0 | 7.5 | 10.4 | 8.0 |
| HMIS 19.6: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Red(Adult) | 2017-18 | 5.7 | 7.1 | 8.2 | 7.7 |
IFA Blue| Year | Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|---|
| 2021-22 | 57.7 | 45.2 | 39.4 | 56.6 | |
| HMIS 19.7: Percentage of stocks available for Iron and Folic Acid (IFA) tablets - Blue (Adolescent 10-19 years) | 2020-21 | 43.6 | 46.7 | 41.0 | 37.4 |
| HMIS 19.7: Percentage of stocks available for Iron and Folic Acid (IFA) tablets - Blue (Adolescent 10-19 years) | 2019-20 | 47.0 | 56.0 | 56.1 | 34.5 |
| HMIS 19.7: Percentage of stocks available for Iron and Folic Acid (IFA) tablets - Blue (Adolescent 10-19 years) | 2018-19 | 58.0 | 51.4 | 40.0 | 31.2 |
| HMIS 19.7: Percentage of stocks available for Iron and Folic Acid (IFA) tablets - Blue (Adolescent 10-19 years) | 2017-18 | 38.7 | 24.3 | 32.2 | 44.9 |
| HMIS 19.7: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Blue(Adolescent 10-19 year) | 2020-21 | 16.7 | 14.3 | 16.8 | 16.1 |
| HMIS 19.7: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Blue(Adolescent 10-19 year) | 2019-20 | 11.9 | 18.7 | 19.5 | 0.9 |
| HMIS 19.7: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Blue(Adolescent 10-19 year) | 2018-19 | 12.2 | 21.8 | 6.9 | 5.3 |
| HMIS 19.7: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Blue(Adolescent 10-19 year) | 2017-18 | 7.1 | 5.6 | 20.4 | 6.5 |
| HMIS 19.7: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Blue(Adolescent 10-19 year) | 2020-21 | 10.6 | 18.5 | 17.4 | 14.5 |
| HMIS 19.7: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Blue(Adolescent 10-19 year) | 2019-20 | 14.4 | 17.7 | 14.3 | 7.9 |
| HMIS 19.7: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Blue(Adolescent 10-19 year) | 2018-19 | 13.7 | 20.0 | 10.3 | 6.5 |
| HMIS 19.7: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Blue(Adolescent 10-19 year) | 2017-18 | 10.0 | 10.3 | 12.5 | 10.8 |
IFA Pink| Year | Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|---|
| 2021-22 | 64.4 | 27.9 | 43.0 | 38.3 | |
| HMIS 19.8: Percentage of stocks available for Iron and Folic Acid (IFA) tablets - Pink (Junior 6-10 years) | 2020-21 | 52.0 | 88.4 | 48.1 | 42.1 |
| HMIS 19.8: Percentage of stocks available for Iron and Folic Acid (IFA) tablets - Pink (Junior 6-10 years) | 2019-20 | 62.5 | 74.6 | 66.6 | 44.8 |
| HMIS 19.8: Percentage of stocks available for Iron and Folic Acid (IFA) tablets - Pink (Junior 6-10 years) | 2018-19 | 58.3 | 39.4 | 41.8 | 52.4 |
| HMIS 19.8: Percentage of stocks available for Iron and Folic Acid (IFA) tablets - Pink (Junior 6-10 years) | 2017-18 | 14.5 | 14.5 | 18.7 | 46.1 |
| HMIS 19.8: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Pink ( Junior 6-10 yrs) | 2020-21 | 18.1 | 17.1 | 11.5 | 15.0 |
| HMIS 19.8: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Pink ( Junior 6-10 yrs) | 2019-20 | 7.5 | 13.1 | 26.8 | 5.3 |
| HMIS 19.8: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Pink ( Junior 6-10 yrs) | 2018-19 | 13.7 | 12.8 | 21.6 | 13.6 |
| HMIS 19.8: Number of Stocks Received for Iron Folic Acid(IFA) tablets - Pink ( Junior 6-10 yrs) | 2017-18 | 2.8 | 2.1 | 10.7 | 20.0 |
| HMIS 19.8: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Pink ( Junior 6-10 yrs) | 2020-21 | 13.8 | 13.5 | 21.8 | 18.3 |
| HMIS 19.8: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Pink ( Junior 6-10 yrs) | 2019-20 | 15.1 | 16.0 | 22.7 | 12.8 |
| HMIS 19.8: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Pink ( Junior 6-10 yrs) | 2018-19 | 16.6 | 12.1 | 15.9 | 16.4 |
| HMIS 19.8: Number of Stocks Distributed for Iron Folic Acid(IFA) tablets - Pink ( Junior 6-10 yrs) | 2017-18 | 7.1 | 5.6 | 4.9 | 4.1 |
Syrup-Paediatric| Year | Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|---|
| 2021-22 | 95.0 | 23.7 | 95.0 | 55.0 | |
| HMIS 19.9: Percentage of stocks available for Iron and Folic Acid (IFA) - Syrup (Paediatric) | 2020-21 | 45.8 | 46.2 | 36.8 | 42.3 |
| HMIS 19.9: Percentage of stocks available for Iron and Folic Acid (IFA) - Syrup (Paediatric) | 2019-20 | 49.4 | 48.9 | 49.8 | 57.7 |
| HMIS 19.9: Percentage of stocks available for Iron and Folic Acid (IFA) - Syrup (Paediatric) | 2018-19 | 36.8 | 73.4 | 49.4 | 49.1 |
| HMIS 19.9: Percentage of stocks available for Iron and Folic Acid (IFA) - Syrup (Paediatric) | 2017-18 | 23.6 | 36.7 | 33.4 | 25.8 |
| HMIS 19.9: Number of Stocks Received for for Iron Folic Acid(IFA) -Syrup (Paediatric) | 2020-21 | 14.1 | 14.4 | 22.1 | 25.2 |
| HMIS 19.9: Number of Stocks Received for for Iron Folic Acid(IFA) -Syrup (Paediatric) | 2019-20 | 15.9 | 18.5 | 16.1 | 20.5 |
| HMIS 19.9: Number of Stocks Received for for Iron Folic Acid(IFA) -Syrup (Paediatric) | 2018-19 | 16.6 | 25.8 | 13.4 | 12.1 |
| HMIS 19.9: Number of Stocks Received for for Iron Folic Acid(IFA) -Syrup (Paediatric) | 2017-18 | 7.2 | 22.0 | 8.3 | 4.9 |
| HMIS 19.9: Number of Stocks Distributed for Iron Folic Acid(IFA) -Syrup (Paediatric) | 2020-21 | 13.8 | 15.5 | 21.9 | 11.4 |
| HMIS 19.9: Number of Stocks Distributed for Iron Folic Acid(IFA) -Syrup (Paediatric) | 2019-20 | 14.8 | 14.7 | 16.2 | 10.4 |
| HMIS 19.9: Number of Stocks Distributed for Iron Folic Acid(IFA) -Syrup (Paediatric) | 2018-19 | 11.9 | 28.1 | 15.1 | 8.9 |
| HMIS 19.9: Number of Stocks Distributed for Iron Folic Acid(IFA) -Syrup (Paediatric) | 2017-18 | 14.3 | 9.5 | 10.7 | 39.6 |
Albendazole 400mg| Year | Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|---|
| HMIS 19.15: Number of Stocks Received for Albendazole 400 mg tablet | 2020-21 | 9.9 | 50.1 | 34.4 | 23.5 |
| HMIS 19.15: Number of Stocks Received for Albendazole 400 mg tablet | 2019-20 | 32.0 | 12.4 | 0.8 | 8.1 |
| HMIS 19.15: Number of Stocks Received for Albendazole 400 mg tablet | 2018-19 | 25.1 | 11.6 | 13.1 | 7.7 |
| HMIS 19.15: Number of Stocks Received for Albendazole 400 mg tablet | 2017-18 | 7.3 | 10.0 | 37.8 | 24.7 |
| HMIS 19.15: Number of Stocks Distributed for Albendazole 400 mg tablet | 2020-21 | 6.6 | 88.0 | 8.8 | 23.7 |
| HMIS 19.15: Number of Stocks Distributed for Albendazole 400 mg tablet | 2019-20 | 14.3 | 19.3 | 3.0 | 9.9 |
| HMIS 19.15: Number of Stocks Distributed for Albendazole 400 mg tablet | 2018-19 | 21.0 | 20.5 | 13.6 | 11.6 |
| HMIS 19.15: Number of Stocks Distributed for Albendazole 400 mg tablet | 2017-18 | 4.6 | 11.5 | 5.8 | 28.1 |